Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The control of hypoglycemic hyperinsulinemic syndrome from malignant insulinoma is challenging because it is often refractory to diazoxide and somatostatin analogues (SA). Everolimus can have side effects that can limit its use. Pasireotide, a multi-receptor-targeted SA with a high binding affinity to SSTR1 and SSTR5, exhibits a strong inhibitory effect of insulin secretion.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Davi' M
Authors: Zambon G, Cosaro E, Cingarlini S, Trombetta M, Landoni L,
Keywords: pasireotide, malignant insulinoma, hypoglycemia,
Introduction: Literature on ectopic Cushing syndrome (ECS) and NET is scarce
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author: Davì M
Authors: Davì M, Cosaro E, Piacentini S, Reimondo G, Albiger N,
Keywords: Ectopic ACTH,
Introduction: Gastroenteropancreatic endocrine tumors (GEP-NETs) are a frequent manifestation of MEN1. They represent an important prognostic factor in these patients. There is still a debate on their management, mainly on surgical strategy, due to their multicentricity and high recurrence rate.
Conference: 13th Annual ENETSConcerence (2016)
Presenting Author:
Authors: Cosaro E, Mella A, Cingarlini S, Grego E, Ortolani S,
Keywords: MEN1, GEP-NET, management,
Introduction: There is a current trend for conservative treatment of non functioning pancreatic NET (NF-PNETs), ≤ 2 cm, in patients with MEN1, which are reported to be associated with low risk of metastasis and death.
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author: Davi' M
Authors: Davì M, Cosaro E, Malpaga A, Butturini G, Ortolani S,
Keywords: Pancreatic neuroendocrine tumor, MEN1,